COVID-19 Vaccine Update: 2023-2024 Talking Points
Updated 2023-2024 Formulations of Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccine Talking Points
Updated 2023-2024 Formulations of Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19 Vaccine Talking Points
This resource provides answers to commonly asked questions regarding immunization stakeholder and partnership strategies
REACH created a list of quality educational resources from trusted sources to assist in improving health equity & COVID-19 vaccination rates.
This tip sheet provides a list of actionable solutions to challenges IPs and partners may face in increasing equitable access to birth dose immunizations.
This resource includes talking points, data, and helpful resources to support decisions to vaccinate children against COVID-19.
In this final episode of REACHing for Vaccine Equity, meet a team using innovative approaches to improve COVID-19 and flu vaccination rates.
AIM conducted listening sessions to gather lessons learned from the pediatric COVID-19 vaccine roll-out for children ages 5-11.
AIM has drafted a template for AAP/AAFP chapters to communicate with members about renewing efforts to protect children from COVID-19.
In this episode of REACHing for Vaccine Equity, learn how activating trusted partners led to vaccine success in this vibrant community with strong family connections.
This report is a detailed overview of the 2024 Adult Vaccine Access Cooperative (VAC) meetings. AIM convened eight regional VAC meetings from May through July 2024 to focus on improving adult vaccination rates. Teams from 59 of 64 CDC-funded immunization…